Article | August 17, 2026

How Can Biopharma Overcome Digital Transformation Failure?

Source: Cytiva

By Martin Ball, Sr. Product Marketing Manager, Automation and Digital, Cytiva

AI, artificial intelligence, medicine technology, digital transformation-GettyImages-2276984949

Digital transformation promises to reshape biopharma manufacturing through automation, advanced analytics, digital twins, AI, and connected processes. Yet many organizations remain stuck between a compelling vision and meaningful, scalable progress. The barrier is not a lack of technology or strategic ambition. It is the complex work of implementation: aligning organizational structures, incentives, workflows, and decision-making across every function involved in manufacturing. Understanding this execution gap is essential for leaders seeking to improve process knowledge, operational performance, and the delivery of therapeutics to patients.

Learn why digital initiatives often fall short, what makes transformation difficult to scale, and how biopharma organizations can begin closing the divide between potential and practical results.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online